Presentation is loading. Please wait.

Presentation is loading. Please wait.

New Modalities in Diabetes Diagnosis Presented By: Kristin J. Brown, MSIV Dr. William M. Scholl College of Podiatric Medicine July 2011 Image source:

Similar presentations


Presentation on theme: "New Modalities in Diabetes Diagnosis Presented By: Kristin J. Brown, MSIV Dr. William M. Scholl College of Podiatric Medicine July 2011 Image source:"— Presentation transcript:

1 New Modalities in Diabetes Diagnosis Presented By: Kristin J. Brown, MSIV Dr. William M. Scholl College of Podiatric Medicine July 2011 Image source:

2 Who Should Be Tested? According to the ADA 1 : Overweight/obese adults BMI >25 Who have one or more additional risk factors At age 45 years Repeat testing every 3 yrs If pre-diabetic, test every year.

3 Methods of Diagnosis  Source: ADA’s “Standards of Medical Care” 1

4 HbA1c vs. FPG & OGTT 1  ≥6.5 diagnose DM  Disadvantages  Higher in cost  Limited availability for testing.  Can be altered in patients with anemia and hemoglobinopathies.  Benefits  Fasting not required  Greater pre-analytical stability than FPG  Less vulnerable to alterations than FPG during stress & illness.

5 FPG 1  Studies have shown the FPG test has a specificity exceeding 96%, but it is only 50% sensitive. 2

6 FPG & OGTT 1  OGTT has been shown to have a sensitivity of 73% and specificity of 80%. 2  Both FPG and OGTT are invasive, fasting exams that suffer from poor reproducibility. 2

7 3 HbA1c Assay Interferences “If your diabetes patient has a hemoglobin variant, your lab should use one of the methods that does not show interference from the variant, thus producing an accurate A1C result.”

8 Complications DDiabetes complications 1,4 : CCVD** PPVD NNephropathy RRetinopathy NNeuropathy PPeripheral and autonomic HHearing loss SStroke HHTN Image source:

9 Neuropathy 1,4  One of the most common late complications of DM.  Leading cause of non-traumatic amputations in the US.  Has a role in other late complications of diabetes.   Neuropathic ulcerations!  Increases risk of mortality.

10 Neuropathy Etiology  AGE’s (Advanced Glycation End products) 5  Increased in hyperglycemia & oxidative stress  Sugars cross-link with other proteins  Contribute to segmental demyelination and interact with nitric oxide  neronal apoptosis.  Excess sugars and proteins broken down by the Maillard reaction 5 :  Creates AGE’s Image source:

11 AGE’s  Increased in skin collagen in those with neuropathy. 5  Especially pentosidine and cross-lines  These when excited with near-UV and blue light. fluoresce Image source:

12 AGE’s  First screened via punch biopsy that often times required a suture for closure. 2  Now studies using near infrared (NIR) technologies. 2  Non-invasive  Portable & immediate results  Readings corrected for intrinsic fluorescence parameters. (dark vs. light skin, etc.) Image source:

13 Studies  M.N. Ediger, B. Olson, and J Maynard. “Noninvasive Optical Screening for Diabetes.” Journal of Diabetes Science & Technology. 2009;3(4):  Retrospective cohort of 2,793 subjects  All identified as naïve & at risk based on the ADA’s Standard of Care Guidelines.  Compared FPG, HbA1c, and OGTT to SIF.  OGTT at 2hr 75g was considered the baseline.  Results

14 Studies  J.D. Maynard et al. “Noninvasive Type 2 Diabetes Screening”. Diabetes Care. 2007;30(5):  351 subjects with one or more DM risk factors.  Ages years  Compared HbA1c, FGT, SIF vs. OGTT  84 pts had AGT (OGTT >140 mg/dL)  Results

15 Studies  B.N. Conway et al. “Skin Intrinsic Fluorescence Correlates with Autonomic and Distal Symmetrical Polyneuropathy in Individuals with Type 1 Diabetes.” Diabetes Care. 2011;34:  111 people with DM1  Mean age 49 years  Determined if CDSP and autonomic neuropathy associated with SIF vs. HbA1c.  Results

16 Scout DS by VeraLight 8 Image source:

17 Scout DS by VeraLight 8 Image source:

18 Scout DS by VeraLight 8 ≥50 =diabetic <50 =normal Image source:

19 Corneal Confocal Microscopy  “A rapid, non-invasive technique that enables a prospective and reiterative evaluation of the human cornea at high magnification [1-2 µm resolution].” 9  Utilizes confocal optics, which allows examination of a focused point. 9  Coronal sections of the cornea.  Can visualize corneal epithelium, Bowman’s membrane (nerve-complex), stroma, and endothelium.  Even better than histopathological exams! 9  Fun fact: The cornea is the most densely innervated part of the human body! 9

20 Corneal Confocal Microscopy Cont…  The cornea contains C and Aδ fibers. 9  Reminder: C fibers are large, unmyelinated fibers responsible for slow, aching pain. Aδ cause fast, sharp pain.  Those fibers account for the majority of symptoms in diabetic neuropathy, and have been shown to be damaged first. 9

21 Study  M. Tavakoli, et al. “Corneal Confocal Microscopy: A novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy.” Diabetes Care. 2010;33(8):  110 DM and 17 healthy pts.  Assessed on NDS, QST, NCV (sural & peroneal), NCCA, CCM.  Results

22 Image source: M. Tavakoli, et al. “Corneal Confocal Microscopy: A novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy.” Diabetes Care. 2010;33(8): O5 normal moderate mild severe

23 Conclusion  Skin Intrinsic Fluorescence and Corneal Confocal Microscopy are two technologies at the forefront of diabetic and diabetic neuropathy diagnosis.  They are non-invasive techniques that give immediate results, and have been shown by multiple studies to be superior to other techniques.  While they aren’t seen widely now, you will probably see them soon…

24 Image source: Thank you. Questions?

25 References 1. American Diabetes Association. “Standards of Medical Care in Diabetes-2010.” Diabetes Care. 2010:33(supplement 1): Hull, E., et al. “Noninvasive, optical detection of diabetes: model studies with porcine skin.” Optics Express. 2004;12(19): Centers for Disease Control & Prevention. “Harmonizing Hemoglobin A1C Testing.” Accessed online July 12 th, American Diabetes Association website. “Living with Diabetes: Complications.” Accessed online July 10, diabetes/complications/http://www.diabetes.org/living-with- diabetes/complications/ 5. Conway, B.N. et al. “Skin Intrinsic Fluorescence Correlates with Autonomic and Distal Symmetrical Polyneuropathy in Individuals with Type 1 Diabetes.” Diabetes Care. 2011;34: Ediger, M.N., B. Olson, and J Maynard. “Noninvasive Optical Screening for Diabetes.” Journal of Diabetes Science & Technology. 2009;3(4): Maynard, J.D. et al. “Noninvasive Type 2 Diabetes Screening”. Diabetes Care. 2007;30(5): VeraLight Website. “The VeraLight Scout DS.” Accessed online July 10 th, Hossain, P., A. Sachdev, and R. Malik. “Early detection of diabetic peripheral neuropathy with corneal confocal microscopy.” The Lancet. 2005;366: Tavakoli, M. et al. “Corneal Confocal Microscopy: A novel and noninvasive test to diagnose and stratify the severity of human diabetic neuropathy.” Diabetes Care. 2010;33(8): Malik, R.A. et al. “Corneal Confocal Microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients.” Diabetologia. 2003;46:


Download ppt "New Modalities in Diabetes Diagnosis Presented By: Kristin J. Brown, MSIV Dr. William M. Scholl College of Podiatric Medicine July 2011 Image source:"

Similar presentations


Ads by Google